Approximately 4% of BCP‐ALL patients harbour IGH::DUX4,5, 6 with most cases displaying a DUX4 reverse insertion in the enhancer region located upstream of the immunoglobulin heavy chain IGH. Here, DUX4 is linked to acute lymphoblastic leukemia.